Growing demand for blood and fluid warming devices to be used for blood transfusion in prehospital emergency setting is triggering the worldwide market growth

calendar_today 07 December, 2022 person_outline Growth Plus Reports

Global blood and fluid warming devices market size was expected at US$ 1.13 billion in 2021 by Growth+ Reports' deep-dive market assessment study. From 2022 to 2030, the market is predicted to grow at a CAGR of 8.92 %.

Before transfusion into a patient, blood or fluids are warmed using blood and fluid warming devices. The preserved fluid needs to be heated to a certain temperature for safe infusion. The injection of cooler fluids into a person could lead to hypothermia and other consequences. In order to prevent hypothermia in patients who have undergone surgery or physical trauma, it is also employed in healthcare facilities to warm fluids, crystalloids, or blood products to body temperatures before being administered (intravenously or through other parenteral routes). The blood warmer has an audible alert system and automatically adjusts temperature to flow rate.
The market is expanding because of the rising number of operations and trauma cases. The rise in dialysis use in advanced stages of a medical patient's condition and illness complexity are related to the rising number of procedures. According to the American Kidney Fund's 2022-updated statistics, 810,000 Americans were estimated to be living with kidney failure as of 2021, and approximately 37 million Americans have kidney disease. These statistics drive the adoption of dialysis machines, which in turn drives the demand for blood warmer devices.

Government and private-sector initiatives enable people to attend equipment demonstrations at facilities that provide patients with useful information about choosing a piece of equipment that is appropriate for their unique condition. For instance, the University of South Carolina in collaboration with The Gerber Foundation and Prisma Health-Midlands performed a clinical trial to administer packed red blo9od cells (PRBC) transfusions to very premature new-borns while using a commercial blood warmer to prevent hypothermic body temperatures (36.5°C). Additionally, the government of U.K. has issued the proper guideline for blood transfusion. In that report, it was clearly mentioned that to maintain the proper temperature of blood and other body fluids the use of warming devices is necessary. 

However, a lack of understanding of blood warming systems in those regions may be preventing growth in new markets. Furthermore, it is anticipated that rising devices development costs and stronger government requirements in developing countries for the clearance of medical devices will hurt the industry.

North America held major market share in 2021 for blood and fluid warming systems. North America is a particularly dominant market as seen by the increased adoption of these systems and the rise in hypothermia cases in this area. North America leads the blood fluid warming system market, followed by Europe. The demand for blood fluid warming devices is increased by the prevalence of ice skating, where accidents and mishaps expose people to subfreezing temperatures, and by below-average temperatures in most countries for several months of the year. This increases demand in certain regions for blood fluid warming systems. The need for blood warmers has increased significantly as a result of the sharp increase in hypothermia-related instances and the rise of chronic conditions like thyroid and diabetes. For instance, according to the CDC's National Diabetes Statistics Report for 2020, 34.2 million Americans experienced diabetes in the last few years. Blood warmers are crucial to surgical therapy; therefore, the market is also predicted to expand as more surgeries are done. For instance, 70% of all spending in the U.S. was on surgical procedures, according to the American Society for Aesthetic Plastic Surgery. Therefore, it is estimated that these variables would have a favourable impact on the market throughout the projected year. On other hand, Asia Pacific is growing faster than other regions, primarily because the amount of diabetes in the region is rising. The Asia-Pacific market will also be driven by an older population on the rise. Because of the cold, Eastern Europe and Japan are also anticipated to develop significantly.

The major players holding the highest revenue of global blood and fluid warming devices are, 3M Healthcare, Becton, Dickinson and Company, Boston Scientific Corporation, Barkey GmbH & Co. KG, Smith & Nephew Group plc., General Electric Company, Cincinnati Sub-Zero Products LLC, Sino Medical-Device Technology Co., Ltd., Meridian Medical Systems LLC, Estill Medical Technologies, Inc. Stryker Corporation, Gentherm Medical, Belmont Medical, ICU Medical, Vyaire Medical, Inc., and The Surgical Company PTM among others.

awards awards key differentiators

Reach Us

Web –

// // // //